One thing I do agree and acknowledge with you @Malcolm1209 is the gifted shares to Management. Read (CEO) increased his holding from ~13M to ~18M without buying on market last FY. It is a balance to reward and maintain high calibre resources but you’ve got to set a bar to achieve the performance shares. Read receives millions of shares to simply maintain employed on top of a healthy salary. Could he be headhunted and poached by another company? Quite possibly, so I’m not violently opposed to the terms but just a bit uneasy. This is small cap land.
In regards to your comment around revenue and market cap. I compare MDR with PCK as I cannot for the life of me see how PCK can be valued at over $200M with $34k of customer receipts in the last quarter. Today they announce a UK BDM and the share price jumps a further 10%. Management here announce a signed UK customer and the market shrugs its shoulders.
It seems all international opportunities are dovetailing into seeing revenues in early 2020. It appears to take many, many months/year from contracts being signed to implementation and roll out. Adheris was named last year if my memory serves me correct.
I’m very comfortable to continue to hold. I hope within a few months the upcoming revenues will be a big enough carrot to see further rises. And still curious what Regal will do with their 75M @ 5c. They have a number of funds and I highly doubt they bought MDR who is a growing company, to short us.
https://www.regalfm.com/site/investments/investments-home#australian-nz-wholesale-investors
Add to My Watchlist
What is My Watchlist?
